Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus organizes the conference “Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease”, planned in Bari on March 4 at 9 am.
Sickle Cell Disease (SCD) is a disease until a few decades ago almost unknown in our countries and today, as a result of migratory flows to Europe, is considered one of the most relevant hematological emergencies in the world. SCD is a serious disease having specific...
The European Commission’s DG Research and Innovation considers DEEP project as an excellent example of fruitful project, working on the integration of the existing information on deferiprone use in paediatric patients, and providing a valid support to the use of the drug in this class of age.
Despite being a common disorder in some regions such as Europe, we cannot forget that Thalassaemia is a rare disease. But nowadays, thanks to blood transfusions and chelation therapy, surviving and life quality of thalassaemic patients have notably improved. The Guide...
Fondazione “Leonardo Giambrone” per la Guarigione dalla Thalassemia onlus, a not-for-profit body founded in 1992 to promote the development of definitive thalassaemia therapies, divulged a press release to promote the development of gene therapy in thalassaemic...
Prof. Adriana Ceci, President of Fondazione Gianni Benzi, participated in the Thalassemia International Federation World Congress 2013, that has been held in Abu Dhabi from 20 to 23 October 2013, with a presentation entitled ‘A multi-ethnic multi-national approach to...
In the General Hospital of Bari’s Federico Vecchio hall, in collaboration with the “Hereditary anemias in the child” CIR of the “F. Vecchio” Pediatric Operating Unit of Bari’s General Hospital, the Gianni Benzi Pharmacological Research Foundation introduced to the...
Recent posts in INHERENT, Updates from projects